Correlation Between Tryp Therapeutics and Adial Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Tryp Therapeutics and Adial Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tryp Therapeutics and Adial Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Tryp Therapeutics and Adial Pharmaceuticals, you can compare the effects of market volatilities on Tryp Therapeutics and Adial Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tryp Therapeutics with a short position of Adial Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tryp Therapeutics and Adial Pharmaceuticals.

Diversification Opportunities for Tryp Therapeutics and Adial Pharmaceuticals

0.0

Correlation Coefficient

Tryp Therapeutics  Adial Pharmaceuticals

Pay attention - limited upside

The 3 months correlation between Tryp and Adial is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Tryp Therapeutics and Adial Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Adial Pharmaceuticals and Tryp Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tryp Therapeutics are associated (or correlated) with Adial Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Adial Pharmaceuticals has no effect on the direction of Tryp Therapeutics i.e., Tryp Therapeutics and Adial Pharmaceuticals go up and down completely randomly.

Pair Corralation between Tryp Therapeutics and Adial Pharmaceuticals

If you would invest (100.00) in Tryp Therapeutics on December 26, 2024 and sell it today you would earn a total of  100.00  from holding Tryp Therapeutics or generate -100.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Tryp Therapeutics  vs.  Adial Pharmaceuticals

Tryp Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Tryp Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Tryp Therapeutics is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Adial Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Adial Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's forward indicators remain quite persistent which may send shares a bit higher in April 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Pair Trading with Tryp Therapeutics and Adial Pharmaceuticals

The main advantage of trading using opposite Tryp Therapeutics and Adial Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tryp Therapeutics position performs unexpectedly, Adial Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adial Pharmaceuticals will offset losses from the drop in Adial Pharmaceuticals' long position.

The idea behind Tryp Therapeutics and Adial Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.